| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Cyclo Therapeutics Inc (NASDAQ: CYTH)
CYTH Technical Analysis
5
| As on 11th Mar 2025 CYTH STOCK Price closed @ 0.68 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.41 & Strong Sell for SHORT-TERM with Stoploss of 1.33 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CYTHSTOCK Price
| Open | 0.70 | Change | Price | % |
| High | 0.75 | 1 Day | -0.02 | -2.86 |
| Low | 0.68 | 1 Week | -0.09 | -11.69 |
| Close | 0.68 | 1 Month | -0.12 | -15.00 |
| Volume | 19594 | 1 Year | -0.98 | -59.04 |
| 52 Week High 1.90 | 52 Week Low 0.55 | ||||
NASDAQ USA Most Active Stocks
| SYRS | 0.14 | 55.56% |
| AMRS | 0.14 | 100.00% |
| BHAT | 0.04 | 33.33% |
| NVDA | 108.76 | 1.66% |
| CUTR | 0.11 | -15.38% |
| AWH | 0.18 | -10.00% |
| TSLA | 230.58 | 3.79% |
| LMDX | 0.02 | 0.00% |
| LCID | 2.09 | 0.48% |
| AAL | 11.46 | -8.32% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CYTH Daily Charts |
CYTH Intraday Charts |
Whats New @ Bazaartrend |
CYTH Free Analysis |
|
|
CYTH Important Levels Intraday
| RESISTANCE | 0.81 |
| RESISTANCE | 0.77 |
| RESISTANCE | 0.74 |
| RESISTANCE | 0.72 |
| SUPPORT | 0.64 |
| SUPPORT | 0.62 |
| SUPPORT | 0.59 |
| SUPPORT | 0.55 |
CYTH Forecast March 2025
| 4th UP Forecast | 2.49 |
| 3rd UP Forecast | 1.91 |
| 2nd UP Forecast | 1.55 |
| 1st UP Forecast | 1.19 |
| 1st DOWN Forecast | 0.17 |
| 2nd DOWN Forecast | -0.19 |
| 3rd DOWN Forecast | -0.55 |
| 4th DOWN Forecast | -1.13 |
CYTH Weekly Forecast
| 4th UP Forecast | 1.53 |
| 3rd UP Forecast | 1.26 |
| 2nd UP Forecast | 1.09 |
| 1st UP Forecast | 0.92 |
| 1st DOWN Forecast | 0.44 |
| 2nd DOWN Forecast | 0.27 |
| 3rd DOWN Forecast | 0.10 |
| 4th DOWN Forecast | -0.17 |
CYTH Forecast2025
| 4th UP Forecast | 3.69 |
| 3rd UP Forecast | 2.72 |
| 2nd UP Forecast | 2.13 |
| 1st UP Forecast | 1.53 |
| 1st DOWN Forecast | -0.17 |
| 2nd DOWN Forecast | -0.77 |
| 3rd DOWN Forecast | -1.36 |
| 4th DOWN Forecast | -2.33 |
Cyclo Therapeutics Inc ( NASDAQ USA Symbol : CYTH )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CYTH Business Profile
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. The company's lead drug candidate is Trappsol Cyclo, an orphan drug for the treatment of Niemann-Pick Type C disease. It also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was founded in 1990 and is based in Gainesville, Florida. Address: 6714 NW 16th Street, Gainesville, FL, United States, 32653
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service